SMTI
Price
$31.61Alerts
Change
-$0.05 (-0.16%)
Updated
Nov 11 closing price
Capitalization
289.88M
139 days until earnings call
Intraday BUY SELL Signals
TMDX
Price
$92.01Alerts
Change
+$1.07 (+1.18%)
Updated
Nov 11 closing price
Capitalization
3.06B
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SMTI vs TMDX

SMTI vs TMDX Comparison Chart in %
View a ticker or compare two or three
VS
SMTI vs. TMDX commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMTI is a Hold and TMDX is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for SMTI with price predictions
Nov 11, 2026

SMTI in downward trend: 10-day moving average crossed below 50-day moving average on October 19, 2026

The 10-day moving average for SMTI crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 57 cases where SMTI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.

The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SMTI as a result. In 59 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

SMTI moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +0.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMTI advanced for three days, in 186 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

SMTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. SMTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SMTI's P/B Ratio (36.493) is very high in comparison to the industry average of (4.964). P/E Ratio (-8.481) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (2.050) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.777) is also within normal values, averaging (56.876).

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TMDX with price predictions
Nov 11, 2026

TMDX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for TMDX turned positive on November 04, 2026. Looking at past instances where TMDX's MACD turned positive, the stock continued to rise in 43 of 49 cases over the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on TMDX as a result. In 76 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

TMDX moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +35.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in 254 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

TMDX broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TMDX entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. TMDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.906) is normal, around the industry mean (4.142). P/E Ratio (19.829) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.709) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.033) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
SMTI vs TMDX: Fundamental Ratings
SMTI
TMDX
OUTLOOK RATING
1..100
5131
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
10065
SMR RATING
1..100
9928
PRICE GROWTH RATING
1..100
4941
P/E GROWTH RATING
1..100
9892
SEASONALITY SCORE
1..100
2350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMDX's Valuation (70) in the Medical Specialties industry is in the same range as SMTI (80) in the null industry. This means that TMDX’s stock grew similarly to SMTI’s over the last 12 months.

TMDX's Profit vs Risk Rating (65) in the Medical Specialties industry is somewhat better than the same rating for SMTI (100) in the null industry. This means that TMDX’s stock grew somewhat faster than SMTI’s over the last 12 months.

TMDX's SMR Rating (28) in the Medical Specialties industry is significantly better than the same rating for SMTI (99) in the null industry. This means that TMDX’s stock grew significantly faster than SMTI’s over the last 12 months.

TMDX's Price Growth Rating (41) in the Medical Specialties industry is in the same range as SMTI (49) in the null industry. This means that TMDX’s stock grew similarly to SMTI’s over the last 12 months.

TMDX's P/E Growth Rating (92) in the Medical Specialties industry is in the same range as SMTI (98) in the null industry. This means that TMDX’s stock grew similarly to SMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SMTITMDX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
74%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 15 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (SMTI: $31.61 vs. TMDX: $92.01)
Brand notoriety: SMTI and TMDX are both not notable
SMTI represents the Pharmaceuticals: Other, while TMDX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: SMTI: 20% vs. TMDX: 79%
Market capitalization -- SMTI: $289.88M vs. TMDX: $3.06B
SMTI [@Pharmaceuticals: Other] is valued at $289.88M. TMDX’s [@Medical/Nursing Services] market capitalization is $3.06B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMTI’s FA Score shows that 0 FA rating(s) are green while TMDX’s FA Score has 1 green FA rating(s).

  • SMTI’s FA Score: 0 green, 5 red.
  • TMDX’s FA Score: 1 green, 4 red.
According to our system of comparison, TMDX is a better buy in the long-term than SMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMTI’s TA Score shows that 3 TA indicator(s) are bullish while TMDX’s TA Score has 4 bullish TA indicator(s).

  • SMTI’s TA Score: 3 bullish, 5 bearish.
  • TMDX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TMDX is a better buy in the short-term than SMTI.

Price Growth

SMTI (@Pharmaceuticals: Other) experienced а -2.23% price change this week, while TMDX (@Medical/Nursing Services) price change was +26.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.07%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was +22.77%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

SMTI is expected to report earnings on Mar 31, 2027.

TMDX is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (+2.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

SMTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMTI has been loosely correlated with A. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SMTI jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
-0.16%
A - SMTI
47%
Loosely correlated
-0.52%
NTRA - SMTI
45%
Loosely correlated
+2.51%
MTD - SMTI
44%
Loosely correlated
-0.14%
TWST - SMTI
44%
Loosely correlated
-7.22%
IQV - SMTI
44%
Loosely correlated
-0.23%
More

TMDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with ATEC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then ATEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMDX
1D Price
Change %
TMDX100%
+1.17%
ATEC - TMDX
37%
Loosely correlated
+5.00%
RDNT - TMDX
35%
Loosely correlated
+0.18%
SMTI - TMDX
34%
Loosely correlated
-0.16%
ALGN - TMDX
33%
Loosely correlated
-1.25%
PODD - TMDX
32%
Poorly correlated
+1.33%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AQLT31.730.34
+1.08%
iShares MSCI Global Quality Factor ETF (AQLT)
GXPC27.470.21
+0.77%
Global X PureCap MSCI Communication Services ETF (GXPC)
PSET79.91N/A
N/A
Principal Quality ETF (PSET)
KBE66.67-0.12
-0.18%
State Street SPDR S&P Bank ETF (KBE)
APHU22.15-0.26
-1.16%
T-REX 2X Long APH Daily Target ETF (APHU)